LAMP1 and non-Hodgkin lymphoma: In this study, the median level of NK cell activity in patients with NHL-LAHS was similar to the lower limit of normal, and CD107a did not reduce in nearly 73% of patients, with no significant differences between B-LAHS and T/NK-LAHS for either of the two indicators (p > 0.05).